The use of recombinant human erythropoietin [rHuEpo] in man.
New York Blood Center, New York 10021.
J W
JW
Adamson
J W
JW
Eschbach
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D001172:Arthritis, Rheumatoid / Q000150:complications; D001804:Blood Transfusion, Autologous; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007249:Inflammation; D007501:Iron / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014655:Vascular Resistance
D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron